|
|
|
|
|
Tamoxifen Citrate USP |
|
Tamoxifen is a medication in pill form that interferes with the activity of estrogen (a female hormone). Tamoxifen has been used for more than 20 years to treat patients with advanced breast cancer. It has also been used as adjuvant, or additional, therapy following surgery or radiation therapy for early stage breast cancer. Tamoxifen has recently been found to reduce the incidence of breast cancer in women at high risk of developing this disease. Tamoxifen continues to be studied for the prevention of breast cancer. It is also being studied in the treatment of several other types of cancer. |
|
Solubility: Slightly soluble in water, slightly soluble in Acetone and soluble in methanol. Loss on Drying: Not more than 0.5% Sulphated Ash: Not more than 0.1% Assay: 99.0% to 101% |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|